Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329.SS)
CNY 29.52
(0.0%)
CNY 29.52
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.59 Billion CNY | 5.66% |
| 2022 | 3.29 Billion CNY | 19.46% |
| 2021 | 2.75 Billion CNY | 7.04% |
| 2020 | 2.57 Billion CNY | -12.59% |
| 2019 | 2.94 Billion CNY | 11.81% |
| 2018 | 2.63 Billion CNY | 19.31% |
| 2017 | 2.2 Billion CNY | 10.4% |
| 2016 | 2 Billion CNY | -4.28% |
| 2015 | 2.09 Billion CNY | -2.8% |
| 2014 | 2.15 Billion CNY | 12.24% |
| 2013 | 1.91 Billion CNY | 7.0% |
| 2012 | 1.79 Billion CNY | 14.34% |
| 2011 | 1.56 Billion CNY | 17.15% |
| 2010 | 1.33 Billion CNY | 21.24% |
| 2009 | 1.1 Billion CNY | 23.77% |
| 2008 | 890.97 Million CNY | 12.59% |
| 2007 | 791.31 Million CNY | 3.79% |
| 2006 | 762.39 Million CNY | -30.11% |
| 2005 | 1.09 Billion CNY | 12.34% |
| 2004 | 971 Million CNY | 10.84% |
| 2003 | 876.02 Million CNY | 26.9% |
| 2002 | 690.34 Million CNY | 18.73% |
| 2001 | 581.43 Million CNY | 62.38% |
| 2000 | 358.06 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.05 Billion CNY | 7.66% |
| 2024 Q2 | 867.5 Million CNY | -17.57% |
| 2024 Q3 | 767.91 Million CNY | -11.48% |
| 2023 Q1 | 1.05 Billion CNY | 3.77% |
| 2023 Q4 | 977.52 Million CNY | 43.12% |
| 2023 FY | 3.48 Billion CNY | 5.66% |
| 2023 Q3 | 683.01 Million CNY | -21.03% |
| 2023 Q2 | 864.93 Million CNY | -17.7% |
| 2022 Q3 | 725.97 Million CNY | -10.43% |
| 2022 Q2 | 810.5 Million CNY | 8.88% |
| 2022 FY | 3.29 Billion CNY | 19.46% |
| 2022 Q1 | 744.42 Million CNY | 46.93% |
| 2022 Q4 | 1.01 Billion CNY | 39.5% |
| 2021 Q3 | 709.95 Million CNY | -7.87% |
| 2021 Q4 | 506.64 Million CNY | -28.64% |
| 2021 FY | 2.75 Billion CNY | 7.04% |
| 2021 Q1 | 769.88 Million CNY | 28.51% |
| 2021 Q2 | 770.62 Million CNY | 0.1% |
| 2020 Q1 | 680.91 Million CNY | -4.85% |
| 2020 FY | 2.57 Billion CNY | -12.59% |
| 2020 Q2 | 699.02 Million CNY | 2.66% |
| 2020 Q3 | 596.85 Million CNY | -14.62% |
| 2020 Q4 | 599.09 Million CNY | 0.37% |
| 2019 Q3 | 698.51 Million CNY | -7.96% |
| 2019 Q1 | 773.83 Million CNY | 21.2% |
| 2019 Q2 | 758.95 Million CNY | -1.92% |
| 2019 FY | 2.94 Billion CNY | 11.81% |
| 2019 Q4 | 715.64 Million CNY | 2.45% |
| 2018 Q3 | 629.89 Million CNY | -2.61% |
| 2018 FY | 2.63 Billion CNY | 19.31% |
| 2018 Q4 | 638.49 Million CNY | 1.36% |
| 2018 Q1 | 720.59 Million CNY | 20.98% |
| 2018 Q2 | 646.8 Million CNY | -10.24% |
| 2017 Q4 | 595.63 Million CNY | 15.8% |
| 2017 Q3 | 514.37 Million CNY | -3.83% |
| 2017 Q2 | 534.88 Million CNY | -5.21% |
| 2017 FY | 2.2 Billion CNY | 10.4% |
| 2017 Q1 | 564.29 Million CNY | 10.55% |
| 2016 Q1 | 532.67 Million CNY | 6.9% |
| 2016 Q4 | 510.44 Million CNY | 5.61% |
| 2016 FY | 2 Billion CNY | -4.28% |
| 2016 Q3 | 483.33 Million CNY | 1.84% |
| 2016 Q2 | 474.61 Million CNY | -10.9% |
| 2015 FY | 2.09 Billion CNY | -2.8% |
| 2015 Q4 | 498.3 Million CNY | 11.77% |
| 2015 Q3 | 445.82 Million CNY | -22.81% |
| 2015 Q2 | 577.56 Million CNY | 1.54% |
| 2015 Q1 | 568.81 Million CNY | -0.84% |
| 2014 Q3 | 478.45 Million CNY | -16.33% |
| 2014 Q2 | 571.8 Million CNY | 8.54% |
| 2014 Q1 | 526.79 Million CNY | 12.28% |
| 2014 FY | 2.15 Billion CNY | 12.24% |
| 2014 Q4 | 573.63 Million CNY | 19.89% |
| 2013 Q3 | 410.63 Million CNY | -16.82% |
| 2013 Q4 | 469.16 Million CNY | 14.25% |
| 2013 Q1 | 542.63 Million CNY | 51.2% |
| 2013 Q2 | 493.67 Million CNY | -9.02% |
| 2013 FY | 1.91 Billion CNY | 7.0% |
| 2012 Q4 | 358.88 Million CNY | -12.29% |
| 2012 Q1 | 513.53 Million CNY | 31.54% |
| 2012 FY | 1.79 Billion CNY | 14.34% |
| 2012 Q2 | 509.24 Million CNY | -0.83% |
| 2012 Q3 | 409.14 Million CNY | -19.66% |
| 2011 Q3 | 357.04 Million CNY | -5.62% |
| 2011 FY | 1.56 Billion CNY | 17.15% |
| 2011 Q1 | 440.44 Million CNY | 33.88% |
| 2011 Q2 | 378.32 Million CNY | -14.1% |
| 2011 Q4 | 390.4 Million CNY | 9.34% |
| 2010 Q3 | 306.89 Million CNY | -10.49% |
| 2010 Q2 | 342.85 Million CNY | -4.28% |
| 2010 Q1 | 358.17 Million CNY | 24.96% |
| 2010 Q4 | 328.98 Million CNY | 7.2% |
| 2010 FY | 1.33 Billion CNY | 21.24% |
| 2009 Q1 | 304.64 Million CNY | 51.9% |
| 2009 FY | 1.1 Billion CNY | 23.77% |
| 2009 Q4 | 286.64 Million CNY | 22.08% |
| 2009 Q3 | 234.8 Million CNY | -15.12% |
| 2009 Q2 | 276.64 Million CNY | -9.19% |
| 2008 Q2 | 241.44 Million CNY | 1.21% |
| 2008 Q3 | 210.42 Million CNY | -12.85% |
| 2008 Q4 | 200.55 Million CNY | -4.69% |
| 2008 Q1 | 238.55 Million CNY | 13.41% |
| 2008 FY | 890.97 Million CNY | 12.59% |
| 2007 Q3 | 160.61 Million CNY | -29.08% |
| 2007 Q4 | 210.34 Million CNY | 30.96% |
| 2007 FY | 791.31 Million CNY | 3.79% |
| 2007 Q1 | 195.34 Million CNY | 110.84% |
| 2007 Q2 | 226.48 Million CNY | 15.94% |
| 2006 Q3 | 164.14 Million CNY | -44.14% |
| 2006 Q1 | 211.75 Million CNY | -38.47% |
| 2006 Q4 | 92.64 Million CNY | -43.56% |
| 2006 FY | 762.39 Million CNY | -30.11% |
| 2006 Q2 | 293.85 Million CNY | 38.77% |
| 2005 Q3 | 232.68 Million CNY | -18.82% |
| 2005 Q4 | 344.12 Million CNY | 47.89% |
| 2005 Q2 | 286.61 Million CNY | 26.03% |
| 2005 FY | 1.09 Billion CNY | 12.34% |
| 2005 Q1 | 227.41 Million CNY | -19.33% |
| 2004 Q4 | 281.9 Million CNY | 35.61% |
| 2004 Q2 | 260.97 Million CNY | 18.5% |
| 2004 FY | 971 Million CNY | 10.84% |
| 2004 Q1 | 220.23 Million CNY | -11.48% |
| 2004 Q3 | 207.87 Million CNY | -20.35% |
| 2003 FY | 876.02 Million CNY | 26.9% |
| 2003 Q4 | 248.8 Million CNY | 39.97% |
| 2003 Q1 | 184.91 Million CNY | -9.32% |
| 2003 Q3 | 177.75 Million CNY | -32.81% |
| 2003 Q2 | 264.55 Million CNY | 43.06% |
| 2002 Q4 | 203.91 Million CNY | 30.01% |
| 2002 Q2 | 179.8 Million CNY | 20.05% |
| 2002 Q1 | 149.77 Million CNY | 0.0% |
| 2002 FY | 690.34 Million CNY | 18.73% |
| 2002 Q3 | 156.84 Million CNY | -12.77% |
| 2001 FY | 581.43 Million CNY | 62.38% |
| 2000 FY | 358.06 Million CNY | 0.0% |